| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Another sphingosine 1-phosphate receptor modulator for the treatment of patients with multiple sclerosis
|
Mowry, Ellen M
|
|
2019
|
18 |
11 |
p. 983-985
|
artikel
|
| 2 |
An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models
|
Dalmau, Josep
|
|
2019
|
18 |
11 |
p. 1045-1057
|
artikel
|
| 3 |
Availability of stroke units in Colombia
|
Bayona-Ortiz, Hernán
|
|
2019
|
18 |
11 |
p. 988
|
artikel
|
| 4 |
Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study
|
van Maurik, Ingrid S
|
|
2019
|
18 |
11 |
p. 1034-1044
|
artikel
|
| 5 |
Correction to Lancet Neurol 2019; 18: 674–83
|
|
|
2019
|
18 |
11 |
p. e9
|
artikel
|
| 6 |
COST Actions: fostering collaborative research for rare diseases
|
Desviat, Lourdes R
|
|
2019
|
18 |
11 |
p. 989-991
|
artikel
|
| 7 |
David Hafler: a ceaseless drive to solve multiple sclerosis
|
Williams, Ruth
|
|
2019
|
18 |
11 |
p. 994
|
artikel
|
| 8 |
Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson's disease: a double-blind, randomised controlled trial
|
van der Kolk, Nicolien M
|
|
2019
|
18 |
11 |
p. 998-1008
|
artikel
|
| 9 |
Exercise in Parkinson's disease: are we narrowing in on the essential elements?
|
Ellis, Terry
|
|
2019
|
18 |
11 |
p. 982-983
|
artikel
|
| 10 |
Global brain inflammation in stroke
|
Shi, Kaibin
|
|
2019
|
18 |
11 |
p. 1058-1066
|
artikel
|
| 11 |
Individuality rooted in the brain's development
|
Woolven, Sophie
|
|
2019
|
18 |
11 |
p. 997
|
artikel
|
| 12 |
Infiltrating on-line patient forums for profit
|
Burton, Adrian
|
|
2019
|
18 |
11 |
p. 992-993
|
artikel
|
| 13 |
Patient-reported outcomes in the spotlight
|
The Lancet Neurology,
|
|
2019
|
18 |
11 |
p. 981
|
artikel
|
| 14 |
Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (RADIANCE): a multicentre, randomised, 24-month, phase 3 trial
|
Cohen, Jeffrey A
|
|
2019
|
18 |
11 |
p. 1021-1033
|
artikel
|
| 15 |
Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (SUNBEAM): a multicentre, randomised, minimum 12-month, phase 3 trial
|
Comi, Giancarlo
|
|
2019
|
18 |
11 |
p. 1009-1020
|
artikel
|
| 16 |
Serendipitous antiepileptics
|
Nisar, Taha
|
|
2019
|
18 |
11 |
p. 995
|
artikel
|
| 17 |
Simiao Wu
|
|
|
2019
|
18 |
11 |
p. 995
|
artikel
|
| 18 |
Sleeping sickness in the Democratic Republic of the Congo
|
Miaka, Erick M
|
|
2019
|
18 |
11 |
p. 988-989
|
artikel
|
| 19 |
The awakened girl
|
De Ambrogi, Marco
|
|
2019
|
18 |
11 |
p. 996-997
|
artikel
|
| 20 |
The dawn of robust individualised risk models for dementia
|
Burnham, Samantha C
|
|
2019
|
18 |
11 |
p. 985-987
|
artikel
|
Tijdschrift beschrijving